Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4245-4251

  Whiting, G C ^a   Rijpkema, S ^a   Adams, T ^a   Corbel, M J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Anthrax; Anthrax vaccine; Two dimensional gel electrophoresis

Indexed keywords

ANTHRAX VACCINE; CELL PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; HEAT SHOCK PROTEIN 60; NUCLEOSIDE DIPHOSPHATE KINASE; PROTEIN S; TOXIN;

ARTICLE; BACTERIAL CELL; DRUG ADSORPTION; DRUG ANALYSIS; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNITED KINGDOM; VACCINE PRODUCTION;

ADSORPTION; ANIMALS; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; DATABASES, FACTUAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MICE; SILVER STAINING;

EID: 4944256095     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.036     Document Type: Article

References (23)

1. L.M. Bush, B.H. Abrams, A. Beall, and C.C. Johnson Index case of fatal inhalational anthrax due to bioterrorism in the United States N. Engl. J. Med. 345 22 2001 1607 1610
2. R. Quintiliani Jr., and R. Quintiliani Fatal case of inhalational anthrax mimicking intra-abdominal sepsis Conn. Med. 66 5 2002 261 267
3. P. Hambleton, J.A. Carman, and J. Melling Anthrax: the disease in relation to vaccines Vaccine 2 2 1984 125 132
4. P.C.B. Turnbull Anthrax vaccines: past, present and future Vaccine 9 8 1991 533 539
5. P.C.B. Turnbull Current status of immunization against anthrax: old vaccines may be here to stay for a while Curr. Opin. Infect. Dis. 13 13 2000 113 120
6. P.S. Brachman, H. Gold, S.A. Plotkin, F.R. Fekety, M. Werrin, and N.R. Ingraham Field evaluation of a human anthrax vaccine Am. J. Publ. Health 52 1962 632 645
7. B.E. Ivins, M.L. Pitt, P.F. Fellows, J.W. Farchans, G.E. Benner, and D.M. Waag Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques Vaccine 16 11-12 1998 1141 1148
8. S. Cohen, I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, and T. Bino Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax Infect. Immun. 68 8 2000 4549 4558
9. M.L. Pitt, S.F. Little, B.E. Ivins, P. Fellows, J. Barth, and J. Hewetson In vitro correlate of immunity in a rabbit model of inhalational anthrax Vaccine 19 32 2001 4768 4773
10. S. Reuveny, M.D. White, Y.Y. Adar, Y. Kafri, Z. Altboum, and Y. Gozes Search for correlates of protective immunity conferred by anthrax vaccine Infect. Immun. 69 5 2001 2888 2893
11. L.M. Joellenbeck, L.L. Zwanziger, J.S. Durch, and B.L. Strom The anthrax vaccine. Is it safe? Does it work? 2002 National Academy Press Washington, DC
12. Anon Surveillance for adverse events associated with anthrax vaccination U.S. Department of Defense, 1998-2000 MMWR 49 16 2000 341 345
13. D.N. Perkins, D.J. Pappin, D.M. Creasy, and J.S. Cottrell Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 18 1999 3551 3567
14. J.A. Gutierrez, and V. Guerriero Jr. Chemical modifications of a recombinant bovine stress-inducible 70 kDa heat-shock protein (Hsp70) mimics Hsp70 isoforms from tissues Biochem. J. 305 1 1995 197 203
15. T. Chitlaru, N. Ariel, A. Zvi, M. Lion, B. Velan, and A. Shafferman Identification of chromosomally encoded membranal polypeptides of Bacillus anthracis by a proteomic analysis: prevalence of proteins containing S-layer homology domains Proteomics 4 3 2004 677 691
16. E. Saile, and T.M. Koehler Control of anthrax toxin gene expression by the transition state regulator abrB J. Bacteriol. 184 2 2002 370 380
17. B.E. Ivins, and S.L. Welkos Recent advances in the development of an improved, human anthrax vaccine Eur. J. Epidemiol. 4 1 1988 12 19
18. S.F. Little, and G.B. Knudson Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig Infect Immun. 52 2 1986 509 512
19. C. Pezard, M. Weber, J.C. Sirard, P. Berche, and M. Mock Protective immunity induced by Bacillus anthracis toxin-deficient strains Infect. Immun. 63 4 1995 1369 1372
20. F. Brossier, M. Weber-Levy, M. Mock, and J.C. Sirard Role of toxin functional domains in anthrax pathogenesis Infect. Immun. 68 4 2000 1781 1786
21. B.M. Price, A.L. Liner, S. Park, S.H. Leppla, A. Mateczun, and D.R. Galloway Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein Infect. Immun. 69 7 2001 4509 4515
22. T. Mignot, S. Mesnage, E. Couture-Tosi, M. Mock, and A. Fouet Developmental switch of S-layer protein synthesis in Bacillus anthracis Mol. Microbiol. 43 6 2002 1615 1627
23. S.H. Kaufmann Heat shock proteins and autoimmunity: a critical appraisal Int. Arch. Allergy Immunol. 103 4 1994 317 322